Physician profile
John Greenfield
NPI 1861406506
$1,506.39
in general payments reported to CMS, 2019-2025
5 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.20 · 2023: $23.66 · 2024: $1,250 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $855 · Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $854.70 |
| Food and Beverage | $627.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,059.70 | 2024 | |
| Stryker Corporation | $171.83 | 2024 | |
| Evolution Surgical, INC | $135.78 | 2025 | |
| Depuy Synthes Sales INC. | $120.87 | 2022-2025 | Na |
| Alexion Pharmaceuticals, INC. | $18.21 | 2024 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Greenfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.